Clinical Study Evaluating the immune responses and safety of lower dose COVID-19 mRNA Vaccination in children (CoVacc) : A Phase 2, Comparative Randomised Trial to Evaluate the impact of reduced COVID-19 mRNA vaccination regimens on immunological responses and reactogenicity in paediatric subjects with and without prior SARS-CoV-2 infection - Immunogenicity and reactogenicity of reduced COVID-19 mRNA vaccination regimens in children (CoVacc)

Medienart:

Klinische Studie

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

WHO International Clinical Trials Registry Platform - (2021) vom: 29. Nov. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Healthy volunteers (paediatric subjects) with or without prior SARS-CoV-2 infection MedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Phase: Phase 2
Recruitment Status: Authorised-recruitment may be ongoing or finished
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 09-10-2021, Last updated: 2022-11-24

ICTRP ID:

EUCTR2021-005043-71-NL
EU-COVPT-1

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007960158